incyte corp (INCY:NASDAQ GS)
Earnings & Estimates Summary - INCYTE CORP (INCY)
2013 revenues at Incyte Corporation totaled $354.9M USD, while annual losses equaled $0.44 per share.
Quarterly Earnings & Estimates - INCYTE CORP (INCY)
Incyte Corporation's Quarterly Earnings
Incyte Corporation reported 2nd quarter 2014 losses of $0.22 per share on 08/2/2014.
Annual Earnings & Estimates - INCYTE CORP (INCY)
Incyte Corporation's Annual Earnings
Incyte Corporation reported annual 2013 losses of $0.44 per share on 02/14/2014.
Quarterly Revenues - INCYTE CORP (INCY)
Incyte Corporation's Quarterly Revenues
Incyte Corporation had 2nd quarter 2014 revenues of $99.6M USD. This missed the $128.9M USD consensus estimate of the 14 analysts following the company. This was -2.1% below the prior year's 2nd quarter results.
Annual Revenues - INCYTE CORP (INCY)
Incyte Corporation's Annual Revenues
Incyte Corporation had revenues for the full year 2013 of $354.9M USD. This was 19.5% above the prior year's results.
|Alkermes PLC||$64.77 USD||+0.43|
|ARIAD Pharmaceuticals Inc||$8.09 USD||-0.18|
|BioMarin Pharmaceutical Inc||$136.73 USD||-0.05|
|Jazz Pharmaceuticals PLC||$177.13 USD||+1.06|
|Vertex Pharmaceuticals Inc||$126.19 USD||+2.71|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|